Treatment
-
ADCs Make Their Mark
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Healthy Habits
Preventing Nerve DamageNew research suggests compression and cold therapy may limit chemotherapy-induced peripheral neuropathy.
by Tyler Santora
-
Forward Look
Bispecific Antibodies to Treat CancerHematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
by Ashley P. Taylor
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast CancerNew oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Tumor-infiltrating LymphocytesAdoptive T-cell therapy shows promise in treating metastatic melanoma.
by Marci A. Landsmann
-
More Prostate Cancer Patients Choose Surveillance
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
-
Post-surgery Option for Liver Cancer
New study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
Forward Look
The Pitfalls of PolypharmacyMany older adults take multiple medications, which can potentially interfere with their cancer treatment.
by Ashley P. Taylor
-
Add It Up
Immunotherapy combination treatments are the first choice for treating many advanced cancers, and more combinations are coming.
by Kendall K. Morgan